The beneficial effect of EllOva® on infertility in PCOS women has been widely proven in literature.

Restoration of the ovulatory function

Observational study
n = 3.602 PCOS women
Treatment protocol: Myo-inositol 4 g + Folic acid 400 μg
Duration: 2-3 months

restored ovulatory function

arrow 70% of infertile PCOS women had retrieved a normal ovulatory function within 2 to 3 months of supplementation.

Improvement of IVF outcomes

Double-blind, randomized study
n = 50 overweight PCOS women undergoing IVF
Duration: 12 weeks
Treatment protocol:
    Treated group (n = 25): Myo-inositol 2 g + Folic acid 400 μg
    Control group (n = 25): Folic acid 400 μg

restored ovulatory function

arrow By increasing the number of top-quality oocytes in PCOS women, Ellova® induced a clinical pregnancy in 40% of treated women vs 16% in the placebo group.